700299 | Farnesol
(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Farnesol
(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
Farnesol is an isoprenoid with the chemical formula C15H26O, which is a common constituent of various essential oils. It is a clear, colorless liquid with a sweet and woody aroma that is produced by a range of plants, including herbs, trees, and shrubs. Farnesol is known for its use in perfumery and aromatherapy owing to its pleasant fragrance and therapeutic properties.
Benefits of Farnesol C15H26O
Farnesol C15H26O has been found to exhibit a range of medically beneficial biological activities, including antibacterial, anti-fungal, and anti-inflammatory properties. It has also been shown to possess insecticidal properties, making it a valuable ingredient in insect repellents. Additionally, Farnesol is believed to have analgesic and sedative effects, which has prompted exploration of its use in treating anxiety, depression, and other related conditions.
Primary Research on Farnesol
The research on farnesol has primarily focused on its chemical composition, biological properties, and applications in different fields. Many studies have explored the production, isolation, and purification of farnesol from various plant sources using different extraction techniques.
Researchers have also investigated the biological activities of farnesol, such as its antimicrobial, anti-inflammatory, and insecticidal properties, using in vitro and in vivo experimental models. Several studies have examined the potential therapeutic applications of farnesol, particularly in the areas of aromatherapy, pain management, and mental health.
Overall, the research on farnesol has provided valuable insights into its chemical and biological properties and potential applications, paving the way for further investigations and developments in the field.
Preclinical and Clinical Studies
Although research on farnesol is still in its early stages, preclinical and clinical studies have provided some promising results regarding its therapeutic potential.
In preclinical studies, farnesol has demonstrated antimicrobial, anti-inflammatory, and anti-tumor activities in various experimental models. Furthermore, farnesol has been shown to possess analgesic and sedative effects, which suggest its potential use in treating anxiety, depression, and pain-related conditions.
Clinical studies on farnesol are limited, but some preliminary research has suggested its potential as a natural insect repellent and as an ingredient in aromatherapy for stress relief and mood enhancement. However, further research is needed to fully understand the safety and efficacy of farnesol in humans, as well as its optimal dosage, route of administration, and potential side effects.
C15H26O
C 81.02%, H 11.79%, O 7.19%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by Bioz- Certificate of Analysis (Lot No. 700299O-25MG-B-010 and 6927OJB010)
- Certificate of Analysis (Lot No. 700299O-25MG-A-010 and 6927OJA010)
- Certificate of Analysis (Lot No. 700299O-25MG-C-010 and 6927OJC010)
